-
1
-
-
27644454204
-
-
M.E. Swartz and I.S. Krull, LCGC 23(10), 1100-1109 (2005).
-
(2005)
LCGC
, vol.23
, Issue.10
, pp. 1100-1109
-
-
Swartz, M.E.1
Krull, I.S.2
-
2
-
-
33748948597
-
-
Mar.-Apr.
-
Pharmacopeial Forum, 31(2), 555 (Mar.-Apr. 2005).
-
(2005)
Pharmacopeial Forum
, vol.31
, Issue.2
, pp. 555
-
-
-
3
-
-
84882305356
-
-
#ORA-LAB.5.4.5, Revised 09/09/2005. See also
-
FDA ORA Laboratory Procedure, #ORA-LAB.5.4.5, Revised 09/09/2005. See also: http://www.fda.gov/ora/science_ref/lm/vol2/section/5_04_05.pdf
-
FDA ORA Laboratory Procedure
-
-
-
4
-
-
0009872542
-
-
Rockville MD, April. See also
-
Guidance for Industry, Changes to an Approved NDA or ANDA, PDA Center for Drug Evaluation and Research, Rockville MD, April 2004. See also: http://www.fda.gov/cder/guidance/index.htm
-
(2004)
Guidance for Industry, Changes to an Approved NDA or ANDA
-
-
-
5
-
-
2342587004
-
-
Rockville, Maryland, February. See also
-
Guidance for Industry, Comparability Protocols-Chemistry, Manufacturing, and Controls Information, PDA Center for Drug Evaluation and Research, Rockville, Maryland, February 2003. See also: http://www.fda.gov/cder/guidance/ index.htm
-
(2003)
Guidance for Industry, Comparability Protocols-Chemistry, Manufacturing, and Controls Information
-
-
-
6
-
-
0031808642
-
-
W.B. Furman, J.G. Dorsey, and L.R. Snyder, Pharm. Technol. 22(6), 58-64 (1998).
-
(1998)
Pharm. Technol.
, vol.22
, Issue.6
, pp. 58-64
-
-
Furman, W.B.1
Dorsey, J.G.2
Snyder, L.R.3
-
7
-
-
33751249388
-
-
May-June
-
Pharmacopeial Forum, 31(3), 825 (May-June 2005).
-
(2005)
Pharmacopeial Forum
, vol.31
, Issue.3
, pp. 825
-
-
-
8
-
-
72749125915
-
-
Nov.-Dec
-
Pharmacopeial Forum, 31(6), 1681 (Nov.-Dec 2005).
-
(2005)
Pharmacopeial Forum
, vol.31
, Issue.6
, pp. 1681
-
-
-
9
-
-
84905357238
-
-
unpublished data on the analysis of tricyclic amines at pH 7.2
-
M.E. Swartz, unpublished data on the analysis of tricyclic amines at pH 7.2.
-
-
-
Swartz, M.E.1
-
12
-
-
33751213135
-
Separation science redefined
-
May
-
Separation Science Redefined, Supplement to LCGC, May 2005.
-
(2005)
Supplement to LCGC
-
-
-
13
-
-
28544450370
-
-
J. Mazzeo, U. Neue, M. Kele, and R. Plumb, Anal. Chem. 277(23), 460A-467A (2005).
-
(2005)
Anal. Chem.
, vol.277
, Issue.23
-
-
Mazzeo, J.1
Neue, U.2
Kele, M.3
Plumb, R.4
-
14
-
-
33746609306
-
-
March-April
-
Pharmacopeial Forum 31(2), 637 (March-April 2005).
-
(2005)
Pharmacopeial Forum
, vol.31
, Issue.2
, pp. 637
-
-
-
15
-
-
33751251438
-
-
May-June
-
Pharmacopeial Forum 32(3), 833 (May-June 2006).
-
(2006)
Pharmacopeial Forum
, vol.32
, Issue.3
, pp. 833
-
-
-
17
-
-
45449119706
-
-
U.S. Food and Drug Administration, Department of Health and Human Services, Rockville, Maryland, September
-
Guidance for Industry, Investigating Out of Specification (OOS) Test Results for Pharmaceutical Production (U.S. Food and Drug Administration, Department of Health and Human Services, Rockville, Maryland, September 1998).
-
(1998)
Guidance for Industry, Investigating out of Specification (OOS) Test Results for Pharmaceutical Production
-
-
|